Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA Fact Sheet  (GLXO)



Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF


Here is the latest financial fact sheet of GSK PHARMA. For more details, see the GSK PHARMA quarterly results and GSK PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

GSK PHARMA Price History

Price Rs 1,889.2
Mkt Cap Rs m 320,042
Vol '000 3.8
P/E X 60.5
P/CF X 47.5
EPS (TTM) Rs 31.2
1 Day % -0.6
No. of shares m 169.41
1 Week % -1.1
1 Month % -4.5
1 Year % 51.1
52 week H/L Rs 2,650.0/1,228.0
As on Apr 18, 2024 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

GSK PHARMA Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
GSK PHARMA EQUITY SHARE DATA
High Rs3,5951,7451,8051,9171,684 
Low Rs1,2531,0461,1551,4001,231 
Sales per share (Unadj.) Rs184.6190.3172.7193.5191.9 
Earnings per share (Unadj.) Rs26.35.517.022.535.9 
Diluted earnings per shareRs26.35.517.022.535.9 
Cash flow per share (Unadj.) Rs29.210.421.626.539.8 
Dividends per share (Unadj.) Rs20.0040.0030.0090.0032.00 
Adj. dividends per shareRs20.0040.0030.0090.0032.00 
Avg Dividend yield %0.82.92.05.42.2 
Book value per share (Unadj.) Rs126.3107.587.3157.2102.9 
Adj. book value per shareRs126.3107.587.3157.2102.9 
Shares outstanding (eoy) m169.41169.41169.41169.41169.41 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x13.17.38.68.67.6 
Avg P/E ratio x92.2253.787.373.840.6 
P/CF ratio (eoy) x83.1134.468.562.636.7 
Price / Book Value ratio x19.213.017.010.614.2 
Dividend payout %76.1727.0176.9400.489.2 
Avg Mkt Cap Rs m410,644236,440250,695280,960246,858 
No. of employees `000NANANANANA 
Total wages/salary Rs m5,3726,2866,1626,1025,950 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
GSK PHARMA INCOME DATA
Net Sales Rs m31,28132,24429,25632,78032,517 
Other income Rs m1,0237901,1067581,007 
Total revenues Rs m32,30433,03430,36233,53833,524 
Gross profit Rs m6,2953,1584,2557,7358,033 
Depreciation Rs m486827786682658 
Interest Rs m663352018 
Profit before tax Rs m6,8273,0584,5407,7908,364 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2,3732,1251,6673,9832,288 
Profit after tax Rs m4,4549322,8733,8086,076 
Gross profit margin %20.19.814.523.624.7 
Effective tax rate %34.869.536.751.127.4 
Net profit margin %14.22.99.811.618.7 
GSK PHARMA BALANCE SHEET DATA
Current assets Rs m33,55917,74820,22537,07924,943 
Current liabilities Rs m28,04110,22013,54616,98413,264 
Net working cap to sales %17.623.322.861.335.9 
Current ratio x1.21.71.52.21.9 
Inventory Days Days35142519197 
Debtors Days Days141113269229216 
Net fixed assets Rs m44,45112,4798,0898,1216,988 
Share capital Rs m1,6941,6941,6941,6941,694 
"Free" reserves Rs m19,70416,51213,08924,93615,735 
Net worth Rs m21,39818,20614,78326,63017,430 
Long term debt Rs m20000 
Total assets Rs m78,04330,22730,11545,20131,930 
Interest coverage x1,233.349.3129.6391.3462.6 
Debt to equity ratio x00000 
Sales to assets ratio x0.41.11.00.71.0 
Return on assets %5.73.39.78.519.1 
Return on equity %20.85.119.414.334.9 
Return on capital %31.917.131.029.348.1 
Exports to sales %00000 
Imports to sales %22.727.139.027.048.1 
Exports (fob) Rs m00000 
Imports (cif) Rs m7,0918,75011,3978,85315,630 
Fx inflow Rs m5342762785281,622 
Fx outflow Rs m7,0918,75011,3978,85315,630 
Net fx Rs m-6,557-8,474-11,119-8,325-14,008 
GSK PHARMA CASH FLOW
From Operations Rs m 4,095 4,905 5,779 8,107 4,842 
From Investments Rs m -1,535 -568 4,180 -4,055 8,079 
From Financial Activity Rs m -3,584 -4,276 -6,956 -5,242 -15,433 
Net Cashflow Rs m -1,023 60 3,004 -1,190 -2,512 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 75.0%
Institution 11.4%
Non-Institution 13.6%
Total 100.0%
Free Float 25.0%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off Gsk House Dr. Annie Besant Road, Worli, Mumbai - 400030
E-mail in.investorquery@gsk.com Web www.gsk-india.com
Tel 022-24959595 Fax 022-24959494
Sector PHARMACEUTICALS Group Glaxo (F) Group
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor Price Waterhouse & Co.
CHM: R S Karnad COMP SEC: Ajay Nadkarni YEAR OF INC: 1924 BSE CODE: 500660 FV (Rs): 10 DIV YIELD (%): 1.7

Read: GSK PHARMA 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    

Compare GSK PHARMA With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    



 

Today's Market

Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results Sensex Today Falls 1,000 Points from Day's High, Slides for 4th Day | Nifty Below 22,100 | Infosys, Bajaj Auto Surge Ahead of Q3 Results(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.